FREELEGAL CASE EVALUATION

Please fill out our easy to use form below. We will contact you today. Or, call us 24/7 TOLL FREE at 877-934-6274.
  • Date Format: MM slash DD slash YYYY
  • By submitting this form you acknowledge that you have read the Terms of Use and accept the terms of this agreement.

News Archives

June 28 2019: CDC and FDA Investigate Papaya Salmonella Outbreak Link

CDC and FDA Investigate Papaya Salmonella Outbreak Papaya Salmonella Outbreak Alert. – The Centers for Disease Control and Prevention (CDC) has announced that along with the Food and Drug Administration (FDA), and state and local public health officials, they are investigating a multistate out break of Salmonella Uganda food poisoning illnesses linked to eating whole, fresh papayas imported from Mexico. The CDC stated that the papayas were sold in Connecticut, Massachusetts, New Jersey, New York, Pennsylvania, and Rhode Island. Papaya Salmonella Outbreak Information The CDC reported that 62 people were infected with the outbreak strain of Salmonella Uganda across 8 states. The numbers of confirmed illnesses by state is as follows: Connecticut (14), Florida (1), Massachusetts (5), New Jersey (12), New York (24), Pennsylvania (4), Rhode Island (1), and Texas (1). Twenty-three people have required hospitalization as a result of Read More

June 21 2019: CDC Provides Update On Multistate Oyster Food Poisoning Outbreak

Multistate Oyster Food Poisoning Outbreak – CDC Food Safety Alert On June 21, 2019, the U.S. Centers for Disease Control and Prevention (CDC) announced that a multistate outbreak of gastrointestinal illnesses linked to eating raw oysters imported from Mexico appears to be over. The CDC reported that a total of 16 persons across five states were sickened in the outbreak. Available illness onset dates ranged from December 16, 2018 through April 17, 2019. Two of the outbreak victims required hospitalization as a result of their illnesses. The oyster food poisoning outbreak investigation, conducted by the CDC, FDA, and state and local public health officials, indicated that raw oysters harvested from Estero El Cardon in Baja California Sur, Mexico, were the likely source of the gastrointestinal illnesses. Multiple Pathogens Responsible For The Oyster Food Poisoning Outbreak The gastrointestinal illnesses linked to Read More

June 13, 2019: FDA Issues Fecal Transplant Warning After Patient Dies From Multi-Drug Resistant Bacterial Infection

FDA Fecal Transplant Warning On June 13, 2019, the FDA warned patients and healthcare professionals of the potential risk for serious or life-threatening infections with the use of fecal microbiota for transplantation (FMT). The warning came after the FDA learned of bacterial infections, including one death, due to the transmission of multi-drug resistant organisms (MDROs) from the use of investigational FMT. Fecal microbiota transplantation, commonly referred to as a “fecal transplant,” is used to treat patients with Clostridium difficile (C. diff) infections that do not respond to standard therapy. A fecal transplant involves the transfer of stool from a healthy donor to the gastrointestinal tract of a patient for the treatment of recurrent C. diff colitis. The bacteria contained in the stool from the healthy donor can help restore the balance of bacteria in the gastrointestinal tract of the patient. Read More

June 7, 2019: Kroger Frozen Blackberry Recall Announced For Hepatitis A Virus Contamination

Kroger Frozen Blackberry Recall Announcement The U.S. Food and Drug Administration (FDA) is alerting the public to hepatitis A virus (HAV) contamination of Kroger grocery store “Private Selection” brand frozen blackberries. The FDA discovered frozen blackberry contamination as a part of their ongoing frozen berry sampling assignment. Consumers are advised by the FDA not to eat the contaminated blackberries and to throw away certain frozen blackberry products purchased from Kroger and other stores sold under Kroger’s “Private Selection” label. Kroger Frozen Blackberry Recall Product Information The following products are subject to the Kroger Frozen Blackberry Recall: • PRIVATE SELECTION FROZEN TRIPLE BERRY MEDLEY, 48 OZ (BEST BY: 07-07-20; UPC: 0001111079120); • PRIVATE SELECTION FROZEN TRIPLE BERRY MEDLEY, 16 OZ (BEST BY: 06-19-20; UPC: 0001111087808); • PRIVATE SELECTION FROZEN BLACKBERRIES, 16 OZ (BEST BY: 06-19-20, 07-02-20; UPC: 0001111087809) The recalled blackberry Read More

March 23, 2019: Henry Avocado Announces Avocado Recall For Potential Listeria Contamination

Avocado Recall Announcement Henry Avocado Corporation has recalled its California-grown whole avocados because the fruits may be contaminated with the pathogen, Listeria monocytogenes. The recalled avocados were sold in bulk at retail stores. The company issued the avocado recall after routine environmental sampling of its California packing facility tested positive for the presence Listeria. About Listeria Listeria is a type of bacteria that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women. Henry Avocado Recall information Avocados subject to the recall include California-grown conventional and organic avocados packed at Henry Avocado’s packing facility in California and distributed in the Read More

FEBRUARY 25, 2019: Xeljanz Side Effects – Increased Risk Of Pulmonary Embolism And Death With Higher Dose Of Tofacitinib (Xeljanz And Xeljanz XR) In Rheumatoid Arthritis Patients Reported

Increased Death and PE Risk Observed in Xeljanz (tofacitinib) Post Marketing Study Xeljanz Side Effects – The US Food and Drug Administration (FDA) announced on February 25, 2019, that data from an ongoing post marketing study has demonstrated an increased risk of pulmonary embolism (PE) and death in rheumatoid arthritis (RA) patients treated with a 10 mg twice daily dose of tofacitinib (marketed as Xeljanz, Xeljanz XR). The FDA has not approved the 10 mg twice daily dose of tofacitinib for rheumatoid arthritis; however, this dose is approved in the treatment of ulcerative colitis. Tofacitinib (Xeljanz, Xeljanz XR) Post Marketing Study Requirement At the time of marketing approval, the FDA required Xeljanz manufacturer, Pfizer, to conduct a post marketing study in patients with RA to evaluate the risk of cardiovascular events, cancer, and opportunistic infections. The study followed patients taking Read More

November 1, 2018: Adenovirus NJ Outbreak Update, 28 Confirmed Cases At Wanaque Center

Adenovirus NJ Outbreak News On November 1, 2018, the New Jersey Department of Health (DOH) reported that another adenovirus case had been confirmed in an ongoing outbreak at the Wanaque Center for Nursing and Rehabilitation in Haskell. To date, a total of 28 confirmed pediatric adenovirus cases have been associated with the outbreak, resulting in 10 deaths. Illness onset dates related to this outbreak range from September 25, 2018 through October 30, 2018. According to the DOH, the Wanaque facility will not admit new residents while the outbreak is ongoing. In addition, a DOH Communicable Disease Service staff member is on site at the facility to monitor the outbreak. About Adenovirus According to the US Centers for Disease Control and Prevention (CDC), adenoviruses can cause a range of illnesses including cold-like symptoms, sore throat, bronchitis, pneumonia, diarrhea, pink eye (conjunctivitis),fever, Read More

November 16, 2018: FDA Warns Of Honey Pacifiers Suspected in Texas Infant Botulism Cases

FDA Reminds Parents Not to Feed Honey to Children Younger Than 1 Year Honey Pacifiers Suspected in Texas Infant Botulism Cases – The U.S. Food and Drug Administration (FDA) is reminding parents and caregivers not to give honey to infants or children younger than one year of age. This includes pacifiers filled with or dipped in honey. La FDA recuerda a los padres que no deben alimentar a los niños menores de 1 año con miel: se sospecha que chupones con miel sean causa de casos de botulismo infantil en Texas – En Espanol. This warning was prompted following reports that four infants in the state of Texas were hospitalized with botulism. According to the FDA all four infants had used pacifiers containing honey. Although these pacifiers were purchased in Mexico, similar products appear to be available in the U.S. Read More

October 25, 2018: NJDOH Investigates Acinetobacter Outbreak at University Hospital, Newark

NJ Acinetobacter Outbreak Announced – The New Jersey Department of Health (DOH) announced that it is investigating four Acinetobacter baumannii infections in the neonatal intensive care unit (NICU) of University Hospital in Newark. About Acinetobacter Acinetobacter is an opportunistic bacterial pathogen mainly affecting people with compromised immune systems. It is a significant healthcare-associated infection. According to the U.S. Centers for Disease Control and Prevention (CDC) Acinetobacter causes a variety of diseases, ranging from pneumonia to serious blood or wound infections, and the symptoms vary depending on the disease.” Acinetobacter can be spread by person-to-person contact or by coming into contact with contaminated surfaces. Infection control procedures, including hand washing and environmental cleaning, can reduce the risk of transmission. New Jersey Department of Health Findings The DOH reports that it first became aware of the Acinetobacter outbreak on October 1, 2018. Read More

August 31, 2018: FDA Announces Recall Montelukast Tablet Recall For Incorrect Drug In Bottles

FDA Montelukast Tablet Recall Announcement The U.S. Food and Drug Administration(FDA) is warning consumers and health care professionals of a recall for one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., of Piscataway, N.J. According to the FDA announcement, the Montelukast Tablet Recall was initiated because sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle from Camber were found to instead contain 90 tablets of Losartan Potassium Tablets, 50 mg. FDA Statement Regarding The Montelukast Tablet Recall This tablet mix-up may pose a safety risk as taking losartan tablets when not prescribed has the potential to cause renal dysfunction, elevated potassium levels and low blood pressure. This risk is especially high for pregnant women taking the allergy and asthma medication montelukast because losartan, which is indicated to treat high blood Read More

If you have a case-specific question, or a question regarding our legal services, please select
Contact Weinberg Law Firm. You may also call us 24/7 at our toll free number, 1(877) 934-6274.